Asbestos-related Diseases

The issue of asbestos exposure and the resulting health problems is now a global problem. The World Health Organization (WHO) has made recommendations on the eradication of asbestos-related diseases. However, malignant mesothelioma, mainly due to asbestos exposure, is a refractory malignant tumor, a...

Description complète

Enregistré dans:
Détails bibliographiques
Format: Online
Langue:anglais
Publié: IntechOpen 2021
Sujets:
Accès en ligne:ONIX_20210420_9781838808334_2721
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1869524799868370944
collection Directory of Open Access Books
description The issue of asbestos exposure and the resulting health problems is now a global problem. The World Health Organization (WHO) has made recommendations on the eradication of asbestos-related diseases. However, malignant mesothelioma, mainly due to asbestos exposure, is a refractory malignant tumor, and technological innovation in diagnosis and treatment is required. In this context, this book describes the immunological effects of asbestos exposure, blood biomarkers, the pathology of malignant mesothelioma, and the status of immune checkpoint drugs in the treatment of malignant mesothelioma, along with the status of MMP mesothelioma. Concerns about health hazards associated with asbestos exposure may persist for many years to come. We hope this book will help researchers in this area.
format Online
id doab-20.500.12854ir-67362
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-673622024-03-31T22:43:34Z Asbestos-related Diseases Otsuki, Takemi Oncology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology The issue of asbestos exposure and the resulting health problems is now a global problem. The World Health Organization (WHO) has made recommendations on the eradication of asbestos-related diseases. However, malignant mesothelioma, mainly due to asbestos exposure, is a refractory malignant tumor, and technological innovation in diagnosis and treatment is required. In this context, this book describes the immunological effects of asbestos exposure, blood biomarkers, the pathology of malignant mesothelioma, and the status of immune checkpoint drugs in the treatment of malignant mesothelioma, along with the status of MMP mesothelioma. Concerns about health hazards associated with asbestos exposure may persist for many years to come. We hope this book will help researchers in this area. 2021-04-20T16:11:31Z 2021-04-20T16:11:31Z 2020 book ONIX_20210420_9781838808334_2721 9781838808334 9781838808327 9781838808341 https://directory.doabooks.org/handle/20.500.12854/67362 eng image/jpeg n/a https://www.intechopen.com/books https://mts.intechopen.com/storage/books/9102/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.83098 10.5772/intechopen.83098 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781838808334 9781838808327 9781838808341 IntechOpen 80 open access
spellingShingle Oncology
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
Asbestos-related Diseases
title Asbestos-related Diseases
title_full Asbestos-related Diseases
title_fullStr Asbestos-related Diseases
title_full_unstemmed Asbestos-related Diseases
title_short Asbestos-related Diseases
title_sort asbestos related diseases
topic Oncology
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
topic_facet Oncology
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
url ONIX_20210420_9781838808334_2721